Ahuja S, Ernst H
Department of Radiology and Nuclear Medicine, Klinikum Steglitz, Free University of Berlin.
Strahlenther Onkol. 1991 Sep;167(9):549-52.
We report on a 32-year-old medullary thyroid carcinoma patient with extensive metastases at the time of diagnosis. In contrast to the osteolytic metastases usually observed in thyroid carcinoma, the patient had osteoblastic bone metastases, assumed to be caused by biologically active tumor calcitonin. The patient died 15 years after initial diagnosis of the advanced tumor. The long survival time may indicate that the prognosis is better for osteoblastic metastases than for osteolytic metastases.
我们报告了一名32岁的甲状腺髓样癌患者,其在诊断时已有广泛转移。与甲状腺癌中通常观察到的溶骨性转移不同,该患者有成骨性骨转移,推测是由具有生物活性的肿瘤降钙素引起的。该患者在晚期肿瘤初次诊断15年后死亡。较长的生存时间可能表明成骨性转移的预后比溶骨性转移更好。